ABEO - ABEONA THERAPEUTICS INC.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 4.81

Open

$ 5.04

Bid

$ 4.80 x 10

Ask

$ 5.44 x 600

Day's Range

$ 4.80 - $ 5.04

52 Week Range

$ 3.93 - $ 7.54

Volume

3,975,871

Average Volume

Market Cap

246.65M

Beta (5Y Monthly)

$ 1.33

PE Ratio (TTM)

$ 4.31

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	03-18-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-29-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-13-2022	03-31-2022	10-Q
15	03-31-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	07-28-2021	06-30-2021	10-Q
18	05-17-2021	03-31-2021	10-Q
19	03-24-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-10-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	03-16-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-09-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	03-18-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-16-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	05-15-2017	03-31-2017	10-Q
35	03-30-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-15-2016	06-30-2016	10-Q
38	05-16-2016	03-31-2016	10-Q
39	03-30-2016	12-31-2015	10-K
40	11-16-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Abeona Secures Permanent CMS J-Code J3389 ...
10/30/2025 14:48:47

Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ser...

Abeona Therapeutics Announced That Its ABO...
10/13/2025 11:34:10

ABO-503 is composed of a functional human RS1 gene packaged in the novel AIM™ capsid AAV204. ABO-503 has shown preclinical effi...

HC Wainwright & Co. Reiterates Buy on Abeo...
10/13/2025 11:18:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 12:13:30

HC Wainwright & Co. Reiterates Buy on Abeo...
08/18/2025 11:08:25

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

Oppenheimer Maintains Outperform on Abeona...
08/15/2025 14:35:36

Oppenheimer analyst Andreas Argyrides maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and raises the price tar...

Abeona Therapeutics Q2 EPS $1.71 Beats $(0...
08/14/2025 11:40:05

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $...

AscellaHealth Partnership With Abeona The...
07/29/2025 14:04:45

BERWYN, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the...

HC Wainwright & Co. Reiterates Buy on Abeo...
07/16/2025 11:34:07

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

Abeona Therapeutics Announced Activation O...
07/15/2025 11:34:43

Bio-Techne's Simple Western Technology Uti...
07/14/2025 11:05:47

Bio-Techne Corporation (NASDAQ:TECH) today announced that its Simple Western™ Technology played a key role in supporting the FD...

HC Wainwright & Co. Reiterates Buy on Abeo...
07/14/2025 10:49:32

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

Abeona Therapeutics Nets $155M From Vouche...
07/02/2025 11:41:50

Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Vo...

Abeona Therapeutics Announces It Has Exerc...
07/01/2025 11:33:41

Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona...

Abeona Therapeutics Added To Russell 2000 ...
06/30/2025 11:35:54

Abeona Announces Publication Of Phase 3 VI...
06/24/2025 11:33:44

RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for ye...

Oppenheimer Assumes Abeona Therapeutics at...
06/02/2025 17:09:07

Oppenheimer analyst Andreas Argyrides assumes Abeona Therapeutics (NASDAQ:ABEO) with a Outperform rating and announces Price...

pdd-holdings-posts-weak-results-joins-ehang-holdings-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

PDD Holdings Posts Weak Results, Joins EHa...
05/27/2025 12:13:03

why-e2open-shares-are-trading-higher-by-25-here-are-20-stocks-moving-premarket

Why E2open Shares Are Trading Higher By 25...
05/27/2025 09:16:35

Stifel Maintains Buy on Abeona Therapeutic...
05/16/2025 17:48:47

Stifel analyst Dae Gon Ha maintains Abeona Therapeutics (NASDAQ:ABEO) with a Buy and lowers the price target from $21 to $20.